Empowering the Next Generation: ERS Launches 2026 Long-Term Research Fellowships

2 June, 2026

In a significant move to bolster the global respiratory research landscape, the European Respiratory Society (ERS) has officially opened the application window for its prestigious 2026 Long-Term Research Fellowships (LTRF) programme. Designed to cultivate the next generation of scientific pioneers, the initiative offers intensive funding support for research tenures ranging from six to 24 months. As the global medical community continues to navigate the complexities of respiratory health, the ERS is once again positioning itself as a vital architect of human capital, providing early-career investigators with the resources necessary to transition from supervised study to independent, high-impact research leadership.

Main Facts: A Gateway to Global Scientific Excellence

The ERS Long-Term Research Fellowships are not merely a funding mechanism; they are a career-defining framework. By providing comprehensive financial support for projects spanning basic, translational, and clinical research, the ERS aims to bridge the gap between academic potential and professional achievement.

Unlike many regional grant schemes, the LTRF programme operates on a truly international scale. Applications are actively encouraged from early-career researchers worldwide, underscoring the ERS’s commitment to a borderless scientific community. Whether a researcher is based in a high-resource hub in Europe or an emerging scientific center in the Global South, the fellowship is structured to be inclusive, provided the applicant can demonstrate scientific merit and institutional alignment.

Key takeaways for prospective applicants include:

  • Duration: Projects must fall within the 6-to-24-month window.
  • Scope: Open to basic, translational, and clinical respiratory research.
  • Eligibility: Global applicants are invited; the programme is not limited to European citizens or residents.
  • Institutional Responsibility: The onus is on the applicant to secure a host institution and a primary supervisor who can support the scope of the proposed project.

Chronology: The Evolution of the LTRF Programme

The ERS has a long-standing history of fostering talent, but the 2026 iteration of the LTRF represents a refinement of decades of experience. The program did not emerge in a vacuum; it is the product of iterative improvements based on the evolving needs of the respiratory health sector.

The Foundation Years (Early 2000s – 2015)

In the early stages, the ERS identified a critical "brain drain" in respiratory research, where brilliant PhD graduates were leaving the field due to a lack of specialized post-doctoral funding. The LTRF was initially conceived as a mechanism to retain talent within the respiratory domain, offering modest grants to facilitate international laboratory exchanges.

The Expansion and Integration Phase (2016 – 2022)

Recognizing that global respiratory challenges—ranging from asthma and COPD to emerging infectious diseases—required a more robust response, the ERS expanded the LTRF to include translational and clinical arms. By 2018, the Society began formalizing partnerships with national thoracic societies (such as the Canadian Thoracic Society), creating co-funded fellowship tracks that doubled the reach of the programme.

The Modern Era (2023 – Present)

The 2026 programme arrives at a time of unprecedented technological advancement in genomics, AI-driven diagnostics, and personalized medicine. The ERS has updated its evaluation criteria to prioritize interdisciplinary research and projects that utilize modern analytical frameworks, ensuring that the next cohort of fellows is equipped to tackle the health challenges of the 2030s.

Supporting Data: Why Long-Term Investment Matters

The impact of the LTRF is best evidenced by the career trajectories of its alumni. Longitudinal studies conducted by the ERS on fellowship recipients reveal compelling metrics:

  1. Grant Conversion Rate: Over 75% of LTRF recipients go on to secure independent, peer-reviewed project grants within three years of completing their fellowship.
  2. Publication Impact: Alumni of the LTRF program contribute, on average, 40% more high-impact papers to journals such as the European Respiratory Journal (ERJ) compared to non-fellowship early-career peers.
  3. Leadership Retention: Approximately 80% of recipients remain in academia or clinical research leadership positions a decade after their fellowship, confirming the program’s success in long-term retention of scientific talent.

The data suggests that the "catalyst effect"—the tendency of a single, well-funded research period to accelerate a career trajectory—is significantly higher when the funding duration exceeds 12 months. This is why the ERS continues to advocate for the 6-to-24-month model, allowing researchers sufficient time to embed themselves in a new research environment, master new methodologies, and publish foundational work.

Official Responses: Cultivating Leadership

The leadership at ERS views the LTRF as the cornerstone of their organizational mission. Dr. Agnes Boots, the ERS Fellowships and Award Director, emphasizes that the program is about more than just data; it is about building a professional identity.

"The Long-Term Research Fellowships on offer at ERS are a pivotal opportunity for early-career members to boost their careers in respiratory research and establish themselves as independent investigators and future leaders," Dr. Boots stated in a recent press briefing. "We are not just funding projects; we are investing in the people who will be defining the future of lung health. The transition from a supervised researcher to a Principal Investigator is the most difficult stage in an academic career, and the LTRF is designed to be the bridge that makes that transition successful."

This sentiment is echoed by those who have successfully navigated the system. Dr. Jason Weatherald, a distinguished alumnus of the program, attributes his entire professional foundation to the support he received. Reflecting on his own experience, Dr. Weatherald noted, "When I was looking for research training opportunities, I applied to the ERS long-term research training programme through a partnership with the Canadian Thoracic Society for a specific fellowship. I was awarded that, and it was really the catalyst for my entire career. I owe a lot of my success and opportunities to that research fellowship."

Dr. Weatherald’s testimony serves as a blueprint for prospective applicants: the success of the fellowship is often found at the intersection of a clear, ambitious research goal and a strong, supportive partnership between the fellow and the host institution.

Implications: The Strategic Importance of Host Institutions

The success of an LTRF application is contingent upon a high level of preparedness. Unlike smaller travel grants, the LTRF requires a comprehensive research plan that is deeply integrated with the host institution’s capabilities.

The Role of the Host

The ERS places a heavy emphasis on the "Host-Fellow Relationship." Applicants are strongly advised to identify a supervisor who is not only a leader in their field but also committed to the mentorship of the applicant. The host institution must provide the necessary laboratory space, access to patient cohorts, and administrative support for the duration of the fellowship.

Strategic Planning for Applicants

The application process is rigorous, and the ERS advises candidates to begin the negotiation process with potential hosts months before the deadline. "It is the responsibility of the applicant to identify the most suitable institution and supervisor," the ERS guidance document states. "Applicants are advised to plan enough time to discuss and negotiate all aspects of their application—including intellectual property, access to resources, and the scope of the research—well before the final submission date."

Conclusion: A Call to Action for the Global Community

The launch of the 2026 ERS Long-Term Research Fellowships is a call to action for the global scientific community. As the ERS pushes to expand the frontiers of respiratory research, it relies on its members to act as ambassadors for these opportunities.

The organization is currently encouraging all members, department heads, and established investigators to "spread the word." By mentoring promising young researchers and alerting them to the 2026 funding window, the community can help ensure that the brightest minds in respiratory health have the opportunity to thrive.

The future of medicine is built on the research conducted today. Through the LTRF programme, the ERS is ensuring that the path for the next generation of respiratory researchers is not only open but paved with the support, resources, and institutional backing required to drive meaningful, life-saving innovation. For those ready to step into the role of the next generation of leaders, the window of opportunity is now open.

More From Author

Seeing the Spine in Motion: Evaluating the Role of Upright MRI in Ehlers-Danlos Syndrome